Development of an in vitro mRNA degradation assay utilizing extracts from HIV-1- and SIV-infected cells

Virology

Volumn 217, Issue 1, 1996, Pages 158-166

  Agy, Michael B ^a   Sherbert, Cynthia H ^a   Katze, Michael G ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; RNA DEGRADATION; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS CELL INTERACTION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0029935066     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.0103     Document Type: Article

References (51)

1. Agy, M. B., Wambach, M., Foy, K., and Katze, M. G. (1990). Expression of cellular genes in CD-4 positive lymphoid cells infected by the human immunodeficiency virus, HIV-1: Evidence for a host protein synthesis shutoff induced by cellular mRNA degradation. Virology 177, 251-258.
2. + human lymphoid cell lines infected by the simian immunodeficiency virus, SIV/Mne. Virology 183, 170-180.
3. Babich, A., Feldman, L., Nevins, J., Darnell, J. E., and Weinberger, C. (1983). Effect of adenovirus on metabolism of specific host mRNAs: Transport control and specific translation discrimination. Mol. Cell Biol. 3, 1212-1221.
4. Barre-Sinoussi, F., Chermann, J. C., Rey, F., Nugeyre, M. T., Chamaret, S., Gruest, J., Dauguet, C., Axler-Blin, C., Vezinet-Brun, F., Rouzioux, C., Rozenbaum, W., and Montagnier, L. (1983). Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220, 868-871.
5. Beelman, C. A., and Parker, R. (1995). Degradation of mRNA in eukaryotes. Cell 81, 179-183.
6. Benveniste, R. E., Arthur, L. O., Tsai, C.-C., Sowder, R., Copland, T. D., Henderson, L. E., and Oroszlan, S. (1986). Isolation of a lentivirus from a macaque with lymphoma: Comparison with HTLV-III/LAV and other lentiviruses. J. Virol. 60, 483-490.
7. Brown, G. D., Peluso, R. W., Moyer, S. A., and Moyer, R. W. (1983). A simple method for the preparation of extracts from animal cells which catalyze efficient in vitro protein synthesis. J. Biol. Chem. 258, 14309-14314.
8. Carrasco, L. (1977). The inhibition of cell functions after viral infection: A proposed general mechanism. FEBS Lett. 767, 11-15.
9. Chackerian, B., Haigwood, N. L., and Overbaugh, J. (1995). Characterization of a CD4 expressing macaque cell line that can detect virus after a single replication cycle and can be infected by diverse simian immunodeficiency virus isolates. Virology 213, 386-394.
10. Chomczynski, P., and Sacchi, N. (1987). angle-step method of RNA isolation by guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
11. Crawford, N., Fire, A., Samules, M., Sharp, P., and Baltimore, D. (1981). Inhibition of transcription factor activity by poliovirus. Cell 22, 555-561.
12. Cullen, B. R. (1986). Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism. Cell 46, 973-982.
13. Daniel, M. D., Letvin, N. L., King, N. W., Kannagi, M., Sehgal, P. K., Kanki, P. J., Essex, M., and Desoriers, R. C. (1985). Isolation of a T-cell tropic HTLV-III-like retrovirus from macaques. Science 228, 1201-1204.
14. Decker, C. J., and Parker, R. (1994). Mechanisms of mRNA degradation in eukaryotes. Trends Biochem. Sci. 19, 336-340.
15. Fenwick, M. L., and Clark, J. (1982). Early and delayed shut-off of host protein synthesis in cells infected with herpes simplex virus. J. Gen. Virol. 61, 121-125.
16. Garfinkel, M. S., and Katze, M. G. (1993). How does influenza virus regulate gene expression at the level of mRNA translation? Let us count the ways. Gene Expr. 3, 109-118.
17. Garfinkel, M. S., and Katze, M. G. (1994). Influenza virus control of protein synthesis. Sci. Am. Sci. Med. 1, 164-73.
18. Heinzinger, N. K., Bukrinsky, M. I., Haggerty, S. A., Ragland, A. M., Kewalramani, V., Lee, M.-A., Gendelman, H., Ratner, L., Stevenson, M., and Emerman, M. (1994). The Vpr protein of human immunodeficiency virus type 1 influences unclear localization of viral nucleic acids in nondividing host cells. Proc. Natl. Acad. Sci. USA 91, 7311-7315.
19. Katze, M. G., and Agy, M. B. (1990). The regulation of viral and cellular RNA turnover in cells infected by eukaryotic viruses including human immunodeficiency virus, HIV-1. Enzyme 44, 332-346.
20. Krikorian, C. R., and Read, G. S. (1991). An in vitro mRNA degradation system to study the virion host shutoff function of herpes simplex virus. J. Virol. 65, 112-122.
21. Letvin, N. L., Li, J., Halloran, M., Cranage, M. P., Rud, E. W., and Sodroski, J. (1995). Prior infection with a nonpathogenic chimeric simian-human immunodeficiency virus does not efficiently protect macaques against challenge with simian immunodeficiency virus. J. Virol. 69, 4569-4571.
22. Levy, D. N., Fernandes, L. S., Williams, W. V., and Weiner, D. B. (1993). Induction of cell differentiation by human immunodeficiency virus 1 vpr. Cell 72, 541-550.
23. Levy, D. N., Refaeli, Y., and Weiner, D. B. (1995). Extracellular vpr protein increases cellular permissiveness to human immunodeficiency virus replication and reactivates virus from latency. J. Virol. 69, 1243-1252.
24. mac virus that expresses the HIV-1 envelope glycoproteins. J. Acquired Immunodeficiency Syndrome 5, 639-646.
25. Maitra, R. K., McMillan, N., Desai, S., McSwiggen, J., Hovanessian, A. G., Sen, G., Williams, B. R. G., and Siverman, R. H. (1994). Activation of two interferon-inducible enzymes by chemically-synthesized HIV-1 TAR RNA. Virology 204, 823-827.
26. Maldarelli, F., Chen, M.-Y., Willey, R. L., and Strebel, K. (1995). Human immunodeficiency virus type 1 vpu protein is an oligomeric type 1 integral membrane. J. Virol. 67, 5056-5061.
27. Mathews, M. B., and Shenk, T. (1990). Control of translation in adenovirus-infected cells. Enzyme 44, 250-264.
28. Oroskar, A. A., and Read, G. S. (1989). Control of mRNA stability by the viron host shutoff function of herpes simplex virus. J. Virol. 63, 1987-1906.
29. Pak, A. S., Everly, D. N., Knight, K., and Read, G. S. (1995). The virion host shutoff protein of herpes simplex virus inhibits reporter gene expression in the absence of other viral gene products. Virology 211, 491-506.
30. Parkin, N. T., Cohen, E. A., Darveau, A., Rosen, C., Haseltine, W., and Sonenberg, N. (1988). Mutational analysis of the 5́ non-coding region of human immunodeficiency virus type 1: Effects of secondary structure on translation. EMBO J. 7, 2831-2837.
31. Pavlakis, G. N., and Felber, B. K. (1990). Regulation of expression of human immunodeficiency virus. N. Biol. 2, 20-31.
32. Read, G. S., and Frenkel, N. (1983). Herpes simplex virus mutants defective in the virion-associated shut-off of host polypeptide synthesis and exhibiting abnormal synthesis of (immediate early) viral peptides. J. Virol. 46, 498-512.
33. Rogel, M. E., Wu, L. I., and Emerman, M. (1995). The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection. J. Virol. 69, 882-888.
34. Rosen, C. A., Sodroski, J., and Haseltine, W. A. (1985). Location of cis-acting regulatory sequences in human T-cell leukemia virus type 1 long terminal repeat. Proc. Natl. Acad. Sci. USA 82, 6502-6506.
35. Ross, J. (1988). Messenger RNA turnover in eukaryotic cells. Mol. Biol. Med. 5, 1-14.
36. Ross, J., and Kobs, G. (1986). H4 histone messenger RNA decay in cell-free extracts initiates at or near 3′ terminus and proceeds 3′ to 5′. J. Mol. Biol. 188, 579-593.
37. Ross, J., Kobs, G., Brewer, G., and Peltz, S. W. (1987). Properties of the exonuclease activity that degrades H4 histone mRNA. J. Biol. Chem. 19, 9374-9381.
38. Schneider, R. J., and Shenk, T. (1987). Impact of virus infection on host cell protein synthesis. Annu. Rev. Biochem. 56, 317-332.
39. Schroder, H. C., Wenger, R., Kuchino, Y., and Muller, W. E. G. (1989). Modulation of nuclear matrix-associated 2′,5′-oligoadenylate metabolism and ribonuclease L activity in H9 cells by human immunodeficiency virus. J Biol. Chem. 264, 5669-5673.
40. Schubert, U., and Strebel, K. (1995). Differential activities of the human immunodeficiency virus type 1-encoded vpu protein are regulated by phosphorylation and occur in different cellular compartments. J. Virol. 68, 2260-2271.
41. Sen, G. C., and Lengyel, P. (1992). The interferon system-A bird's eye view of its biochemistry. J. Biol. Chem. 267, 5017-5020.
42. Smibert, C. A., Johnson, D. C., and Smiley, J. R. (1992). Identification and characterization of the virion-induced host shutoff product of herpes simplex virus gene UL41. J. Gen. Virol. 73, 467-470.
43. Sonenberg, N. (1987). Regulation of translation by poliovirus. Adv. Virus Res. 33, 175-204.
44. Sorenson, C. M., Hart, P. A., and Ross, J. (1991). Analysis of herpes simplex virus-induced mRNA destabilizing activity using an in vitro mRNA decay system. Nucleic Acids Res. 19, 4459-4465.
45. Steffy, K., and Wong-Staal, F. (1991). Genetic regulation of human immunodeficiency virus. Microbiol. Rev. 55, 193-205.
46. Strebel, K., Klimkait, T., Maldarelli, F., and Martin, M. A. (1989). Molecular and biochemical analyses of human immunodeficiency virus type 1 vpu protein. J Virol. 63, 3784-3791.
47. Tanzer, M. M., and Meagher, R. B. (1994). Faithful degradation of soybean rbcS mRNA in vitro. Mol. Cell Biol. 14, 2640-2650.
48. Thomas, P. S. (1980). Hybridization of denatured RMA and small DNA fragments transferred to nitrocellulose. Proc. Natl. Acad. Sci. USA 77, 5201-5205.
49. Trono, D. (1995). HIV accessory proteins: Leading roles for the supporting cast. Cell 82, 189-192.
50. Wain-Hobson, S., Vartanian, J. P., Henry, M., Chenciner, N., Cheynier, R., Delassus, S., Martins, L. P., Sala, M., Nugeure, M. T., and Gu'etard, D. (1991). LAI revisited: Origins of the early HIV-1 isolates from Institut Pasteur. Science 252, 961-965.
51. Willey, R. L., Maldarelli, F., Martin, M. A., and Strebel, K. (1992). Human immunodeficiency virus type 1 vpu protein induces rapid degradation of CD4. J. Virol. 66, 7193-7200.